Olsson CG - Search Results

1

Oral anticoagulants in calf-vein thrombosis.

Lagerstedt C, Olsson CG, Fagher B, Oqvist B, Albrechtsson U. Lagerstedt C, et al. Among authors: olsson cg. Lancet. 1985 Dec 7;2(8467):1311-2. doi: 10.1016/s0140-6736(85)91600-9. Lancet. 1985. PMID: 2866380 No abstract available.

2

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

Wilcox RG, von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR. Wilcox RG, et al. Among authors: olsson cg. Lancet. 1988 Sep 3;2(8610):525-30. doi: 10.1016/s0140-6736(88)92656-6. Lancet. 1988. PMID: 2900919 Clinical Trial.

3

Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis.

Wilcox RG, von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR. Wilcox RG, et al. Among authors: olsson cg. Lancet. 1990 May 19;335(8699):1175-8. Lancet. 1990. PMID: 1971034 Clinical Trial.

4

Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis.

Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U. Lagerstedt CI, et al. Among authors: olsson cg. Lancet. 1985 Sep 7;2(8454):515-8. doi: 10.1016/s0140-6736(85)90459-3. Lancet. 1985. PMID: 2863541 Clinical Trial.

5

Thrombotic side-effects of lower-limb phlebography.

Albrechtsson U, Olsson CG. Albrechtsson U, et al. Among authors: olsson cg. Lancet. 1976 Apr 3;1(7962):723-4. doi: 10.1016/s0140-6736(76)93094-4. Lancet. 1976. PMID: 56537

6

Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study.

Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG. Alikhan R, et al. Among authors: olsson cg. Blood Coagul Fibrinolysis. 2003 Jun;14(4):341-6. doi: 10.1097/00001721-200306000-00004. Blood Coagul Fibrinolysis. 2003. PMID: 12945875 Clinical Trial.

7

Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism.

Verstraete M, Miller GA, Bounameaux H, Charbonnier B, Colle JP, Lecorf G, Marbet GA, Mombaerts P, Olsson CG. Verstraete M, et al. Among authors: olsson cg. Circulation. 1988 Feb;77(2):353-60. doi: 10.1161/01.cir.77.2.353. Circulation. 1988. PMID: 3123091 Clinical Trial.

8

Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.

Fiessinger JN, Lopez-Fernandez M, Gatterer E, Granqvist S, Kher A, Olsson CG, Söderberg K. Fiessinger JN, et al. Among authors: olsson cg. Thromb Haemost. 1996 Aug;76(2):195-9. Thromb Haemost. 1996. PMID: 8865530 Clinical Trial.

9

Thromboprophylaxis with dalteparin in medical patients: which patients benefit?

Cohen AT, Turpie AG, Leizorovicz A, Olsson CG, Vaitkus PT, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Cohen AT, et al. Among authors: olsson cg. Vasc Med. 2007 May;12(2):123-7. doi: 10.1177/1358863X07079017. Vasc Med. 2007. PMID: 17615800 Clinical Trial.

10

Thrombosis after phlebography: a comparison of two contrast media.

Albrechtsson U, Olsson CG. Albrechtsson U, et al. Among authors: olsson cg. Cardiovasc Radiol. 1979;2(1):9-18. doi: 10.1007/BF02552011. Cardiovasc Radiol. 1979. PMID: 526976

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results